Pneumatic displacement and intravitreal bevacizumab for management of submacular hemorrhage in choroidal neovascular membrane

Indian Journal of Ophthalmology

Volumn 58, Issue 2, 2010, Pages 170-171

  Agarwal, Manisha ^a   Chaudhary, S P ^a   Narula, Ritesh ^a   Rajpal, Simpy ^a  

^a DR SHROFF S CHARITY EYE HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ARTICLE; CASE REPORT; HUMAN; IMMUNOLOGY; INTRAOCULAR DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PRESSURE; RETINA HEMORRHAGE; SUBRETINAL NEOVASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; COMBINED MODALITY THERAPY; HUMANS; INJECTIONS, INTRAOCULAR; MALE; MIDDLE AGED; PRESSURE; RETINAL HEMORRHAGE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77949603714     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.60078     Document Type: Article

References (2)

1. Chawla S, Misra V, Khemcandani M. Pneumatic displacement and intravitreal bevacizumab: A new approach for management of submacular hemorrhage in choroidal neovascular membrane. Indian J Ophthalmol 2009;57:155-157
2. Tennant TS, Borrillo JL, Regillo CD. Management of submacular hemorrhage. Ophthalmol Clin N Am 2002;15:445-452